Recently, the "2025 Nanjing Unicorn, Cultivation Unicorn, and Gazelle Enterprise List" was officially announced. Nanjing Xingyin Pharmaceutical Group Co., Ltd. was successfully selected as a gazelle enterprise list based on its innovative breakthroughs and rapid growth in the field of biomedicine. The achievement of this honor signifies that Nanjing Xingyin Pharmaceutical has become an emerging force in promoting high-quality regional economic development in terms of technology research and development, market expansion, and industry influence.

The selection of Nanjing Xingyin Pharmaceutical as a Gazelle Enterprise this time is not only a reflection of the company\\'s innovation strength, but also a microcosm of the thriving development of the biopharmaceutical industry ecology in Lishui District. With the increasing policy support and the emergence of industrial cluster effects, Xingyin Pharmaceutical is expected to accelerate its leap into an industry unicorn like a "gazelle", injecting new momentum into the construction of Lishui into a leading national innovative city.